ESAB (NYSE: ESAB) CEO trades shares under Rule 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
ESAB Corp President and CEO Shyam Kambeyanda reported a mix of option exercises, restricted stock unit activity, and share sales. On February 23, 2026, he exercised employee stock options covering 59,404 shares of common stock at $33.49 per share and converted 4,466 restricted stock units into common shares.
He then sold 59,404 common shares in open-market transactions at weighted-average prices ranging from $122.460 to $128.950 per share under a previously adopted Rule 10b5-1 trading plan. Following these transactions, he directly owns 102,239 shares of common stock and 4,467 restricted stock units. A total of 2,091 shares were withheld to satisfy tax obligations related to the vesting of restricted stock units.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 59,404 shares ($7,353,631)
Net Sell
11 txns
Insider
Kambeyanda Shyam
Role
President and CEO
Sold
59,404 shs ($7.35M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 59,404 | $0.00 | -- |
| Exercise | Restricted Stock Units | 4,466 | $0.00 | -- |
| Exercise | Common stock, par value $0.001 | 59,404 | $33.49 | $1.99M |
| Sale | Common stock, par value $0.001 | 32,286 | $122.998 | $3.97M |
| Sale | Common stock, par value $0.001 | 12,705 | $123.716 | $1.57M |
| Sale | Common stock, par value $0.001 | 10,813 | $124.996 | $1.35M |
| Sale | Common stock, par value $0.001 | 1,300 | $125.79 | $164K |
| Sale | Common stock, par value $0.001 | 600 | $127.864 | $77K |
| Sale | Common stock, par value $0.001 | 1,700 | $128.752 | $219K |
| Exercise | Common stock, par value $0.001 | 4,466 | $0.00 | -- |
| Tax Withholding | Common stock, par value $0.001 | 2,091 | $122.65 | $256K |
Holdings After Transaction:
Employee Stock Option (right to buy) — 0 shares (Direct);
Restricted Stock Units — 4,467 shares (Direct);
Common stock, par value $0.001 — 159,268 shares (Direct)
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.460 to $123.455, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.460 to $124.430, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.465 to $125.390, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.495 to $125.940, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.375 to $128.200, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.560 to $128.950, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (7) to this Form 4. Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. The remaining restricted stock units will vest on February 22, 2027.
FAQ
What did ESAB (ESAB) CEO Shyam Kambeyanda report in this Form 4?
Shyam Kambeyanda reported exercising employee stock options and restricted stock units, then selling common shares. The filing details option exercises for 59,404 shares, conversion of 4,466 restricted stock units, and multiple open-market sales of 59,404 shares executed on February 23, 2026.
What stock option and RSU activity did ESAB (ESAB) disclose for the CEO?
The filing shows an exercise of employee stock options covering 59,404 shares at $33.49 per share and the conversion of 4,466 restricted stock units. Each restricted stock unit represents a contingent right to receive one ESAB common share, as described in the footnotes.